Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00966550 · ClinicalTrials.gov registry record · NA

A Study of Tomato Products and Disease Risk

A NA study of Inflammation, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT00966550: Completed NA study of Inflammation, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

NCT00966550 is a NA study of Inflammation that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 25 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00966550, a NA study of Inflammation, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test whether certain compounds in tomatoes will help reduce factors in the subject's blood associated with disease risk. The investigators want to know if the tomato-associated compounds will lower or improve the status of these factors, like cholesterol and inflammation. In this research study, the subject will be asked to consume high fat test meals on two separate occasions. The investigators want to see how the subject's body responds to a standard high fat meal, one meal with tomato products and one meal without tomato products. The investigators will measure the subject's blood throughout the study period to determine if consumption of tomato products reduces factors in their blood associated with disease risk.

Conditions Studied

Interventions

  • OTHER Tomato
  • OTHER Non-tomato

Study Locations (1)

Illinois

  • Clinical Nutrition Research Center - Chicago

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2009-08
Est. Completion 2012-02
Phase NA

What the finished NCT00966550 record still lists

NCT00966550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Tomato is the first listed.

NCT00966550 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00966550 about?

NCT00966550 is a clinical study titled "A Study of Tomato Products and Disease Risk". The purpose of this research study is to test whether certain compounds in tomatoes will help reduce factors in the subject's blood associated with disease risk. The investigators want to know if the tomato-associated compounds will lower or improve the status of these factors, like cholesterol and ...

What is the current status of trial NCT00966550?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2009-08. Estimated completion is 2012-02.

What conditions does trial NCT00966550 study?

This clinical trial studies the following conditions: Inflammation.

What interventions are being tested in trial NCT00966550?

The interventions under investigation include: Tomato (OTHER), Non-tomato (OTHER).

Who is sponsoring clinical trial NCT00966550?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00966550 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00966550's enrollment target sits among peer trials

25 113th of 132 higher than 17 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00966550, the US trial registry maintained by the National Library of Medicine. NCT00966550 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.